{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360004232561707776.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.ymgme.2012.01.010"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S1096719212000145?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S1096719212000145?httpAccept=text/plain"}},{"identifier":{"@type":"PMID","@value":"22305854"}},{"identifier":{"@type":"NAID","@value":"20001581219"}}],"resourceType":"学術雑誌論文(journal article)","dc:title":[{"@value":"Fabry disease: Biochemical, pathological and structural studies of the α-galactosidase A with E66Q amino acid substitution"}],"description":[{"notation":[{"@value":"Recently, male subjects harboring the c.196GC nucleotide change which leads to the E66Q enzyme having low α-galactosidase A (GLA) activity have been identified at an unexpectedly high frequency on Japanese and Korean screening for Fabry disease involving dry blood spots and plasma/serum samples. Individuals with the E66Q enzyme have been suspected to have the later-onset Fabry disease phenotype leading to renal and cardiac disease. However, there has been no convincing evidence for this. To determine whether c.196GC (E66Q) is disease-causing or not, we performed biochemical, pathological and structural studies. It was predicted that the E66Q amino acid substitution causes a small conformational change on the molecular surface of GLA, which leads to instability of the enzyme protein. However, biochemical studies revealed that subjects harboring the E66Q enzyme exhibited relatively high residual enzyme activity in white blood cells, and that there was no accumulation of globotriaosylceramide in cultured fibroblasts or an increased level of plasma globotriaosylsphingosine in these subjects. An electron microscopic examination did not reveal any pathological changes specific to Fabry disease in biopsied skin tissues from a male subject with the E66Q enzyme. These results strongly suggest that the c.196GC is not a pathogenic mutation but is a functional polymorphism."}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1030566608623409153","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"80260983"},{"@type":"NRID","@value":"1000080260983"},{"@type":"NRID","@value":"9000004512829"},{"@type":"NRID","@value":"9000004513259"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/read0029824"}],"foaf:name":[{"@value":"Tadayasu Togawa"}]},{"@id":"https://cir.nii.ac.jp/crid/1420001326233104512","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"50632783"},{"@type":"NRID","@value":"1000050632783"},{"@type":"NRID","@value":"9000398802014"},{"@type":"NRID","@value":"9000006800139"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/takahiro_tsukimura"}],"foaf:name":[{"@value":"Takahiro Tsukimura"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004232561707904","@type":"Researcher","foaf:name":[{"@value":"Takashi Kodama"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004232561707907","@type":"Researcher","foaf:name":[{"@value":"Toshie Tanaka"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004232561707908","@type":"Researcher","foaf:name":[{"@value":"Ikuo Kawashima"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004232561707780","@type":"Researcher","foaf:name":[{"@value":"Seiji Saito"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004232561707906","@type":"Researcher","foaf:name":[{"@value":"Kazuki Ohno"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004232561707785","@type":"Researcher","foaf:name":[{"@value":"Tomoko Fukushige"}]},{"@id":"https://cir.nii.ac.jp/crid/1030003658790398976","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"70177509"},{"@type":"NRID","@value":"1000070177509"},{"@type":"NRID","@value":"9000402501135"},{"@type":"NRID","@value":"9000006261659"}],"foaf:name":[{"@value":"Takuro Kanekura"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004232561707776","@type":"Researcher","foaf:name":[{"@value":"Atsushi Satomura"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004232561707777","@type":"Researcher","foaf:name":[{"@value":"Duk-Hee Kang"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004232561707783","@type":"Researcher","foaf:name":[{"@value":"Beom Hee Lee"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004232561707784","@type":"Researcher","foaf:name":[{"@value":"Han-Wook Yoo"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004232561707778","@type":"Researcher","foaf:name":[{"@value":"Kent Doi"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004232561707779","@type":"Researcher","foaf:name":[{"@value":"Eisei Noiri"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004232561707905","@type":"Researcher","foaf:name":[{"@value":"Hitoshi Sakuraba"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"10967192"}],"prism:publicationName":[{"@value":"Molecular Genetics and Metabolism"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2012-04","prism:volume":"105","prism:number":"4","prism:startingPage":"615","prism:endingPage":"620"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","https://www.elsevier.com/legal/tdmrep-license","https://doi.org/10.15223/policy-017","https://doi.org/10.15223/policy-037","https://doi.org/10.15223/policy-012","https://doi.org/10.15223/policy-029","https://doi.org/10.15223/policy-004"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S1096719212000145?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S1096719212000145?httpAccept=text/plain"}],"createdAt":"2012-01-19","modifiedAt":"2025-10-21","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=Male","dc:title":"Male"},{"@id":"https://cir.nii.ac.jp/all?q=Models,%20Molecular","dc:title":"Models, Molecular"},{"@id":"https://cir.nii.ac.jp/all?q=Heterozygote","dc:title":"Heterozygote"},{"@id":"https://cir.nii.ac.jp/all?q=DNA%20Mutational%20Analysis","dc:title":"DNA Mutational Analysis"},{"@id":"https://cir.nii.ac.jp/all?q=Immunoblotting","dc:title":"Immunoblotting"},{"@id":"https://cir.nii.ac.jp/all?q=Real-Time%20Polymerase%20Chain%20Reaction","dc:title":"Real-Time Polymerase Chain Reaction"},{"@id":"https://cir.nii.ac.jp/all?q=Asian%20People","dc:title":"Asian People"},{"@id":"https://cir.nii.ac.jp/all?q=Humans","dc:title":"Humans"},{"@id":"https://cir.nii.ac.jp/all?q=Cells,%20Cultured","dc:title":"Cells, Cultured"},{"@id":"https://cir.nii.ac.jp/all?q=Aged","dc:title":"Aged"},{"@id":"https://cir.nii.ac.jp/all?q=Skin","dc:title":"Skin"},{"@id":"https://cir.nii.ac.jp/all?q=Aged,%2080%20and%20over","dc:title":"Aged, 80 and over"},{"@id":"https://cir.nii.ac.jp/all?q=Trihexosylceramides","dc:title":"Trihexosylceramides"},{"@id":"https://cir.nii.ac.jp/all?q=Fibroblasts","dc:title":"Fibroblasts"},{"@id":"https://cir.nii.ac.jp/all?q=Middle%20Aged","dc:title":"Middle Aged"},{"@id":"https://cir.nii.ac.jp/all?q=Microscopy,%20Electron","dc:title":"Microscopy, Electron"},{"@id":"https://cir.nii.ac.jp/all?q=Phenotype","dc:title":"Phenotype"},{"@id":"https://cir.nii.ac.jp/all?q=Amino%20Acid%20Substitution","dc:title":"Amino Acid Substitution"},{"@id":"https://cir.nii.ac.jp/all?q=Child,%20Preschool","dc:title":"Child, Preschool"},{"@id":"https://cir.nii.ac.jp/all?q=alpha-Galactosidase","dc:title":"alpha-Galactosidase"},{"@id":"https://cir.nii.ac.jp/all?q=Mutation","dc:title":"Mutation"},{"@id":"https://cir.nii.ac.jp/all?q=Fabry%20Disease","dc:title":"Fabry Disease"}],"project":[{"@id":"https://cir.nii.ac.jp/crid/1040000782085916032","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"21591438"},{"@type":"JGN","@value":"JP21591438"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-21591438/"}],"notation":[{"@language":"ja","@value":"CD147/Basiginを標的とした新たな皮膚癌治療戦略の構築"},{"@language":"en","@value":"Development of new therapeutic strategy for skin cancers targeting CD147/Basigin"}]},{"@id":"https://cir.nii.ac.jp/crid/1040282257050269312","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"21390314"},{"@type":"JGN","@value":"JP21390314"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-21390314/"}],"notation":[{"@language":"ja","@value":"リソソーム酵素と基質類似体との分子間作用の熱力学的・構造学的研究と新規治療法開発"},{"@language":"en","@value":"Thermodynamic and structural study on the interaction of an enzyme and a substrate analogue for development of new therapy for lysosomal diseases"}]}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050574201775383808","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A new mutation found in newborn screening for Fabry disease evaluated by plasma globotriaosylsphingosine levels"}]},{"@id":"https://cir.nii.ac.jp/crid/1050845763844329216","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"p.E66Q mutation in the GLA gene is associated with a high risk of cerebral small-vessel occlusion in elderly Japanese males"},{"@value":"p.<scp>E</scp>66<scp>Q</scp> mutation in the <scp><i>GLA</i></scp> gene is associated with a high risk of cerebral small‐vessel occlusion in elderly <scp>J</scp>apanese males"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002216793587968","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Newborn screening for Fabry disease in Japan: prevalence and genotypes of Fabry disease in a pilot study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004232562091264","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Fabry disease in a Japanese population-molecular and biochemical characteristics"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004237533164160","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Development of a Highly Sensitive Immuno-PCR Assay for the Measurement of α-Galactosidase A Protein Levels in Serum and Plasma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283695105188736","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Screening of Male Dialysis Patients for Fabry Disease by Plasma Globotriaosylsphingosine"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285707166793856","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Screening for Fabry disease in patients with left ventricular hypertrophy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285708386870912","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"High-throughput screening identified disease-causing mutants and functional variants of α-galactosidase A gene in Japanese male hemodialysis patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285712546105088","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Nano-LC-MS/MS for Quantification of Lyso-Gb3 and Its Analogues Reveals a Useful Biomarker for Fabry Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292619904074752","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Plasma globotriaosylsphingosine as a biomarker of Fabry disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292620226470528","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset<i>GLA</i>mutation c.936+919G>A (IVS4+919G>A)"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567187491009536","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Comparative Study of Structural Changes Caused by Different Substitutions at the Same Residue on α-Galactosidase A"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567188577164672","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Lipid Biomarkers for the Peroxisomal and Lysosomal Disorders: Their Formation, Metabolism and Measurement"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846641723849472","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Prevalence of Fabry disease and GLA c.196G>C variant in Japanese stroke patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848661745449216","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Familial hypertrophic obstructive cardiomyopathy with the GLA E66Q mutation and zebra body"}]},{"@id":"https://cir.nii.ac.jp/crid/1361131417270885376","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Newborn screening for Fabry disease in the western region of Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699994202921984","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Accurate modeling of the intramolecular electrostatic energy of proteins"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699995423577472","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Fabry disease: Detection of undiagnosed hemodialysis patients and identification of a “renal variant” phenotype1"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699995659626240","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"High Incidence of Later-Onset Fabry Disease Revealed by Newborn Screening*"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981469365932416","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Molecular and structural studies of the GM2 gangliosidosis 0 variant"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262943956762496","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Structural characterization of mutant α-galactosidases causing Fabry disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262945920743552","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Point mutations in the upstream region of the ?-galactosidase A gene exon 6 in an atypical variant of Fabry disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825894669346304","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Use of a Modified α-N-Acetylgalactosaminidase in the Development of Enzyme Replacement Therapy for Fabry Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107368846719616","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Calculation of the reaction field due to off-center point multipoles"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107368847009024","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Structural and immunocytochemical studies on α-N-acetylgalactosaminidase deficiency (Schindler/Kanzaki disease)"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107369011328896","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Mutant α-galactosidase A enzymes identified in Fabry disease patients with residual enzyme activity: biochemical characterization and restoration of normal intracellular processing by 1-deoxygalactonojirimycin"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107369084735872","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Molecular genetic, biochemical, and clinical studies in three families with cardiac Fabry’s disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107370214646144","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Differential assay for lysosomal alpha-galactosidases in human tissues and its application to Fabry's disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388844978956544","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Generation of One Set of Murine Monoclonal Antibodies Specific for Globo-Series Glycolipids: Evidence for Differential Distribution of the Glycolipids in Rat Small Intestine"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388845352698624","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Screening for Fabry Disease in Patients with Chronic Kidney Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388846068623744","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Long-term therapy with agalsidase alfa for Fabry disease: safety and effects on renal function in a home infusion setting"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388846326648192","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Long-Term Effects of Enzyme Replacement Therapy on Fabry Cardiomyopathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670320160901760","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The Molecular Defect Leading to Fabry Disease: Structure of Human α-Galactosidase"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670320474436096","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Fabry disease: Characterization of ?-galactosidase A double mutations and the D313Y plasma enzyme pseudodeficiency allele"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951794523620096","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Novel mutations of the GLA gene in Japanese patients with Fabry disease and their functional characterization by active site specific chaperone"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951796227439104","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"dentification of Fabry’s disease by the screening of a-galactosidase A activity in male and female hemodialysis patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233268217386496","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Algorithms for calculating excluded volume and its derivatives as a function of molecular conformation and their use in energy minimization"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233268625652352","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Mutations of the GLA gene in Korean patients with Fabry disease and frequency of the E66Q allele as a functional variant in Korean newborns"}]},{"@id":"https://cir.nii.ac.jp/crid/1370569869084503169","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A discussion of the solution for the best rotation to relate two sets of vectors"}]},{"@id":"https://cir.nii.ac.jp/crid/1370569869084503174","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A solution for the best rotation to relate two sets of vectors"}]},{"@id":"https://cir.nii.ac.jp/crid/1370569869084503178","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Polarizable atomic multipole water model for molecular mechanics simulation"}]},{"@id":"https://cir.nii.ac.jp/crid/1370569869084503300","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Analysis and application of potential energy smoothing for global optimization"}]},{"@id":"https://cir.nii.ac.jp/crid/1370569869084503303","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"α-Galactosidase A deficiency: Fabry disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204876656128","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A Patient with the <i>GLA</i> p.E66Q Mutation Exhibiting Vascular Parkinsonism and Bilateral Pulvinar Lesions"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679853349504","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Pathological Renal Findings of Chronic Renal Failure in a Patient with the E66Q Mutation in the α-galactosidase A Gene"},{"@value":"Pathological Renal Findings of Chronic Renal Failure in a Patient with the E66Q Mutation in the &alpha;-galactosidase A Gene"}]},{"@id":"https://cir.nii.ac.jp/crid/1521417755706408320","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"Newborn screening for Fabry disease in Japan : prevalence and genotypes of Fabry disease in a pilot study"}]},{"@id":"https://cir.nii.ac.jp/crid/2050870367072104576","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Significance of screening for Fabry disease among male dialysis patients"}]},{"@id":"https://cir.nii.ac.jp/crid/2051714792004510720","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Role of the p.E66Q variant of GLA in the progression of chronic kidney disease"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.ymgme.2012.01.010"},{"@type":"CIA","@value":"20001581219"},{"@type":"KAKEN","@value":"PRODUCT-12931647"},{"@type":"KAKEN","@value":"PRODUCT-12724796"},{"@type":"OPENAIRE","@value":"doi_dedup___::2a3ac7e1d7b49ec8f4066e028f976887"},{"@type":"CROSSREF","@value":"10.1038/jhg.2013.48_references_DOI_IqhqJ2qtBRFkzneionY1fHGOfTX"},{"@type":"CROSSREF","@value":"10.1111/ene.12214_references_DOI_IqhqJ2qtBRFkzneionY1fHGOfTX"},{"@type":"CROSSREF","@value":"10.1371/journal.pone.0078588_references_DOI_IqhqJ2qtBRFkzneionY1fHGOfTX"},{"@type":"CROSSREF","@value":"10.2215/cjn.08780812_references_DOI_IqhqJ2qtBRFkzneionY1fHGOfTX"},{"@type":"CROSSREF","@value":"10.1038/hgv.2017.2_references_DOI_IqhqJ2qtBRFkzneionY1fHGOfTX"},{"@type":"CROSSREF","@value":"10.1038/jhg.2012.68_references_DOI_IqhqJ2qtBRFkzneionY1fHGOfTX"},{"@type":"CROSSREF","@value":"10.1371/journal.pone.0127048_references_DOI_IqhqJ2qtBRFkzneionY1fHGOfTX"},{"@type":"CROSSREF","@value":"10.1371/journal.pone.0084267_references_DOI_IqhqJ2qtBRFkzneionY1fHGOfTX"},{"@type":"CROSSREF","@value":"10.2217/bmm-2017-0225_references_DOI_IqhqJ2qtBRFkzneionY1fHGOfTX"},{"@type":"CROSSREF","@value":"10.1038/jhg.2017.31_references_DOI_IqhqJ2qtBRFkzneionY1fHGOfTX"},{"@type":"CROSSREF","@value":"10.1007/s10157-014-0969-y_references_DOI_IqhqJ2qtBRFkzneionY1fHGOfTX"},{"@type":"CROSSREF","@value":"10.1186/s12872-016-0262-y_references_DOI_IqhqJ2qtBRFkzneionY1fHGOfTX"},{"@type":"CROSSREF","@value":"10.1016/j.ymgmr.2018.10.004_references_DOI_IqhqJ2qtBRFkzneionY1fHGOfTX"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.54.3279_references_DOI_IqhqJ2qtBRFkzneionY1fHGOfTX"},{"@type":"CROSSREF","@value":"10.1016/j.ymgmr.2019.100562_references_DOI_IqhqJ2qtBRFkzneionY1fHGOfTX"},{"@type":"CROSSREF","@value":"10.1016/j.ijcard.2012.10.076_references_DOI_IqhqJ2qtBRFkzneionY1fHGOfTX"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.54.4437_references_DOI_IqhqJ2qtBRFkzneionY1fHGOfTX"}]}